Medicare AdvantageCoverageMedium impact
MA05.060f, External Infusion Pumps
Independence Blue Cross·Endocrinology, Oncology, Pain Management +2 more·Pharmacy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated policy MA05.060f to MA05.060h, retroactively effective 01/01/2026, adding HCPCS code J7799 (NOC drugs administered through DME) as medically necessary for external infusion pump coverage. This expands coverage to include non-specified drugs beyond the previously listed conditions (chronic iron overload, chemotherapy, intractable pain, and diabetes).
Action Required
By 01/01/2026 (retroactive): Billing team must update billing system and claim submission processes to recognize J7799 as a medically necessary HCPCS code for external infusion pump coverage under Independence Blue Cross Medicare Advantage plans. Verify that claims submitted on or after 01/01/2026 with J7799 paired with qualifying pump codes (E0779, E0780, E0781, E0784, E0787) are not denied for lack of medical necessity. Review any claims denied between 01/01/2026 and policy implementation date for potential resubmission. Train billing staff on the expanded drug coverage criteria and ensure prior authorization protocols are updated if required for J7799 claims. Contact IBX for clarification on whether J7799 requires prior authorization or supporting documentation for approval.